San Francisco’s Francisco Partners, a technology-focused private equity firms, has finalized its acquisition of Reston, Va.-based QuadraMed Corp.
QuadraMed says its common stockholders are entitled to receive $8.50 in cash for each share of common stock they own, and QuadraMed’s Series A Preferred Stockholders are entitled to receive $13.7097 per share for each share of QuadraMed’s Series A Preferred Stock owned, other than dissenting shares. As a result of the acquisition, QuadraMed says its common stock will no longer be listed for trading on the NASDAQ Global Market.
QuadraMed’s stockholders of record will receive a letter of transmittal and instructions on how to surrender their its shares in exchange for the acquisition consideration, and should wait to receive the letter of transmittal before surrendering their shares.
